Report cover image

Global Cell And Gene Therapy Clinical Trials Databank Market Report

Publisher Magna Intelligence
Published Apr 26, 2024
Length 100 Pages
SKU # MAIN18749865

Description

Global Cell And Gene Therapy Clinical Trials Databank Market Report


The Cell And Gene Therapy Clinical Trials market was valued at $25,130.0 Million in 2020, and is projected to reach $43,026.4 Million by 2029 growing at a CAGR of 6.20% from 2021 to 2029. Cardiology segment is expected to be the highest contributor to this market, with $9,361.8 Million in 2020, and is anticipated to reach $16,753.6 Million by 2029, registering a CAGR of 6.72%. Cardiology and Oncology segments collectively expected to account for about 65.5% share of the Cell And Gene Therapy Clinical Trials market in 2020, with the former constituting around 37.3% share. Cardiology and Oncology segments are expected to witness significant growth rates at a CAGR of 6.72% and 5.94% respectively, during the forecast period. Presently, share of these two segments is estimated to be around 65.5% in the overall Cell And Gene Therapy Clinical Trials market in 2020, and is anticipated to reach 66.6% by 2029.

Table of Contents

100 Pages
1. Global Cell And Gene Therapy Clinical Trials Market, By Application
1.1. Overview
1.2. Cardiology
1.2.1 Cardiology Market, By Region
1.2.1.1 North America Cardiology Market, By Country
1.2.1.2 Europe Cardiology Market, By Country
1.2.1.3 Asia-Pacific Cardiology Market, By Country
1.2.1.4 Rest of World Cardiology Market, By Country
1.3. Oncology
1.3.1 Oncology Market, By Region
1.3.1.1 North America Oncology Market, By Country
1.3.1.2 Europe Oncology Market, By Country
1.3.1.3 Asia-Pacific Oncology Market, By Country
1.3.1.4 Rest of World Oncology Market, By Country
1.4. CNS
1.4.1 CNS Market, By Region
1.4.1.1 North America CNS Market, By Country
1.4.1.2 Europe CNS Market, By Country
1.4.1.3 Asia-Pacific CNS Market, By Country
1.4.1.4 Rest of World CNS Market, By Country
1.5. Other Applications
1.5.1 Other Applications Market, By Region
1.5.1.1 North America Other Applications Market, By Country
1.5.1.2 Europe Other Applications Market, By Country
1.5.1.3 Asia-Pacific Other Applications Market, By Country
1.5.1.4 Rest of World Other Applications Market, By Country
2. Global Cell And Gene Therapy Clinical Trials Market, By Phase
2.1. Overview
2.2. Phase I
2.2.1 Phase I Market, By Region
2.2.1.1 North America Phase I Market, By Country
2.2.1.2 Europe Phase I Market, By Country
2.2.1.3 Asia-Pacific Phase I Market, By Country
2.2.1.4 Rest of World Phase I Market, By Country
2.3. Phase II
2.3.1 Phase II Market, By Region
2.3.1.1 North America Phase II Market, By Country
2.3.1.2 Europe Phase II Market, By Country
2.3.1.3 Asia-Pacific Phase II Market, By Country
2.3.1.4 Rest of World Phase II Market, By Country
2.4. Other Phases
2.4.1 Other Phases Market, By Region
2.4.1.1 North America Other Phases Market, By Country
2.4.1.2 Europe Other Phases Market, By Country
2.4.1.3 Asia-Pacific Other Phases Market, By Country
2.4.1.4 Rest of World Other Phases Market, By Country
3. Global Cell And Gene Therapy Clinical Trials Market, By Region
3.1. Overview
3.2. North America
3.2.1 North America Cell And Gene Therapy Clinical Trials Market, By Application
3.2.2 North America Cell And Gene Therapy Clinical Trials Market, By Phase
3.2.3 North America Cell And Gene Therapy Clinical Trials Market, By Country
3.2.3.1 U.S.
3.2.3.1.1 U.S. Cell And Gene Therapy Clinical Trials Market, By Application
3.2.3.1.2 U.S. Cell And Gene Therapy Clinical Trials Market, By Phase
3.2.3.2 Canada
3.2.3.2.1 Canada Cell And Gene Therapy Clinical Trials Market, By Application
3.2.3.2.2 Canada Cell And Gene Therapy Clinical Trials Market, By Phase
3.2.3.3 Mexico
3.2.3.3.1 Mexico Cell And Gene Therapy Clinical Trials Market, By Application
3.2.3.3.2 Mexico Cell And Gene Therapy Clinical Trials Market, By Phase
3.3. Europe
3.3.1 Europe Cell And Gene Therapy Clinical Trials Market, By Application
3.3.2 Europe Cell And Gene Therapy Clinical Trials Market, By Phase
3.3.3 Europe Cell And Gene Therapy Clinical Trials Market, By Country
3.3.3.1 Germany
3.3.3.1.1 Germany Cell And Gene Therapy Clinical Trials Market, By Application
3.3.3.1.2 Germany Cell And Gene Therapy Clinical Trials Market, By Phase
3.3.3.2 France
3.3.3.2.1 France Cell And Gene Therapy Clinical Trials Market, By Application
3.3.3.2.2 France Cell And Gene Therapy Clinical Trials Market, By Phase
3.3.3.3 U.K.
3.3.3.3.1 U.K. Cell And Gene Therapy Clinical Trials Market, By Application
3.3.3.3.2 U.K. Cell And Gene Therapy Clinical Trials Market, By Phase
3.3.3.4 Italy
3.3.3.4.1 Italy Cell And Gene Therapy Clinical Trials Market, By Application
3.3.3.4.2 Italy Cell And Gene Therapy Clinical Trials Market, By Phase
3.3.3.5 Spain
3.3.3.5.1 Spain Cell And Gene Therapy Clinical Trials Market, By Application
3.3.3.5.2 Spain Cell And Gene Therapy Clinical Trials Market, By Phase
3.3.3.6 Rest of Europe
3.3.3.6.1 Rest of Europe Cell And Gene Therapy Clinical Trials Market, By Application
3.3.3.6.2 Rest of Europe Cell And Gene Therapy Clinical Trials Market, By Phase
3.4. Asia-Pacific
3.4.1 Asia-Pacific Cell And Gene Therapy Clinical Trials Market, By Application
3.4.2 Asia-Pacific Cell And Gene Therapy Clinical Trials Market, By Phase
3.4.3 Asia-Pacific Cell And Gene Therapy Clinical Trials Market, By Country
3.4.3.1 China
3.4.3.1.1 China Cell And Gene Therapy Clinical Trials Market, By Application
3.4.3.1.2 China Cell And Gene Therapy Clinical Trials Market, By Phase
3.4.3.2 India
3.4.3.2.1 India Cell And Gene Therapy Clinical Trials Market, By Application
3.4.3.2.2 India Cell And Gene Therapy Clinical Trials Market, By Phase
3.4.3.3 Japan
3.4.3.3.1 Japan Cell And Gene Therapy Clinical Trials Market, By Application
3.4.3.3.2 Japan Cell And Gene Therapy Clinical Trials Market, By Phase
3.4.3.4 Australia
3.4.3.4.1 Australia Cell And Gene Therapy Clinical Trials Market, By Application
3.4.3.4.2 Australia Cell And Gene Therapy Clinical Trials Market, By Phase
3.4.3.5 South Korea
3.4.3.5.1 South Korea Cell And Gene Therapy Clinical Trials Market, By Application
3.4.3.5.2 South Korea Cell And Gene Therapy Clinical Trials Market, By Phase
3.4.3.6 Rest of Asia
3.4.3.6.1 Rest of Asia Cell And Gene Therapy Clinical Trials Market, By Application
3.4.3.6.2 Rest of Asia Cell And Gene Therapy Clinical Trials Market, By Phase
3.5. Rest of World
3.5.1 Rest of World Cell And Gene Therapy Clinical Trials Market, By Application
3.5.2 Rest of World Cell And Gene Therapy Clinical Trials Market, By Phase
3.5.3 Rest of World Cell And Gene Therapy Clinical Trials Market, By Country
3.5.3.1 Brazil
3.5.3.1.1 Brazil Cell And Gene Therapy Clinical Trials Market, By Application
3.5.3.1.2 Brazil Cell And Gene Therapy Clinical Trials Market, By Phase
3.5.3.2 South Africa
3.5.3.2.1 South Africa Cell And Gene Therapy Clinical Trials Market, By Application
3.5.3.2.2 South Africa Cell And Gene Therapy Clinical Trials Market, By Phase
3.5.3.3 GCC
3.5.3.3.1 GCC Cell And Gene Therapy Clinical Trials Market, By Application
3.5.3.3.2 GCC Cell And Gene Therapy Clinical Trials Market, By Phase
3.5.3.4 RoW Countries
3.5.3.4.1 RoW Countries Cell And Gene Therapy Clinical Trials Market, By Application
3.5.3.4.2 RoW Countries Cell And Gene Therapy Clinical Trials Market, By Phase
RoW Countries Cell And Gene Therapy Clinical Trials Market Value, By Phase, 2020-2029, Million USD LIST OF TABLES
TABLE 1. Global Cell And Gene Therapy Clinical Trials Market Value, By Application, 2020-2029, Million USD
TABLE 2. Cardiology Market Value, By Region, 2020-2029, Million USD
TABLE 3. North America Cardiology Market Value, By Country, 2020-2029, Million USD
TABLE 4. Europe Cardiology Market Value, By Country, 2020-2029, Million USD
TABLE 5. Asia-Pacific Cardiology Market Value, By Country, 2020-2029, Million USD
TABLE 6. Rest of World Cardiology Market Value, By Country, 2020-2029, Million USD
TABLE 7. Oncology Market Value, By Region, 2020-2029, Million USD
TABLE 8. North America Oncology Market Value, By Country, 2020-2029, Million USD
TABLE 9. Europe Oncology Market Value, By Country, 2020-2029, Million USD
TABLE 10. Asia-Pacific Oncology Market Value, By Country, 2020-2029, Million USD
TABLE 11. Rest of World Oncology Market Value, By Country, 2020-2029, Million USD
TABLE 12. CNS Market Value, By Region, 2020-2029, Million USD
TABLE 13. North America CNS Market Value, By Country, 2020-2029, Million USD
TABLE 14. Europe CNS Market Value, By Country, 2020-2029, Million USD
TABLE 15. Asia-Pacific CNS Market Value, By Country, 2020-2029, Million USD
TABLE 16. Rest of World CNS Market Value, By Country, 2020-2029, Million USD
TABLE 17. Other Applications Market Value, By Region, 2020-2029, Million USD
TABLE 18. North America Other Applications Market Value, By Country, 2020-2029, Million USD
TABLE 19. Europe Other Applications Market Value, By Country, 2020-2029, Million USD
TABLE 20. Asia-Pacific Other Applications Market Value, By Country, 2020-2029, Million USD
TABLE 21. Rest of World Other Applications Market Value, By Country, 2020-2029, Million USD
TABLE 22. Global Cell And Gene Therapy Clinical Trials Market Value, By Phase, 2020-2029, Million USD
TABLE 23. Phase I Market Value, By Region, 2020-2029, Million USD
TABLE 24. North America Phase I Market Value, By Country, 2020-2029, Million USD
TABLE 25. Europe Phase I Market Value, By Country, 2020-2029, Million USD
TABLE 26. Asia-Pacific Phase I Market Value, By Country, 2020-2029, Million USD
TABLE 27. Rest of World Phase I Market Value, By Country, 2020-2029, Million USD
TABLE 28. Phase II Market Value, By Region, 2020-2029, Million USD
TABLE 29. North America Phase II Market Value, By Country, 2020-2029, Million USD
TABLE 30. Europe Phase II Market Value, By Country, 2020-2029, Million USD
TABLE 31. Asia-Pacific Phase II Market Value, By Country, 2020-2029, Million USD
TABLE 32. Rest of World Phase II Market Value, By Country, 2020-2029, Million USD
TABLE 33. Other Phases Market Value, By Region, 2020-2029, Million USD
TABLE 34. North America Other Phases Market Value, By Country, 2020-2029, Million USD
TABLE 35. Europe Other Phases Market Value, By Country, 2020-2029, Million USD
TABLE 36. Asia-Pacific Other Phases Market Value, By Country, 2020-2029, Million USD
TABLE 37. Rest of World Other Phases Market Value, By Country, 2020-2029, Million USD
TABLE 38. Global Cell And Gene Therapy Clinical Trials Market Value, By Region, 2020-2029, Million USD
TABLE 39. North America Cell And Gene Therapy Clinical Trials Market Value, By Application, 2020-2029, Million USD
TABLE 40. North America Cell And Gene Therapy Clinical Trials Market Value, By Phase, 2020-2029, Million USD
TABLE 41. North America Cell And Gene Therapy Clinical Trials Market Value, By Country, 2020-2029, Million USD
TABLE 42. U.S. Cell And Gene Therapy Clinical Trials Market Value, By Application, 2020-2029, Million USD
TABLE 43. U.S. Cell And Gene Therapy Clinical Trials Market Value, By Phase, 2020-2029, Million USD
TABLE 44. Canada Cell And Gene Therapy Clinical Trials Market Value, By Application, 2020-2029, Million USD
TABLE 45. Canada Cell And Gene Therapy Clinical Trials Market Value, By Phase, 2020-2029, Million USD
TABLE 46. Mexico Cell And Gene Therapy Clinical Trials Market Value, By Application, 2020-2029, Million USD
TABLE 47. Mexico Cell And Gene Therapy Clinical Trials Market Value, By Phase, 2020-2029, Million USD
TABLE 48. Europe Cell And Gene Therapy Clinical Trials Market Value, By Application, 2020-2029, Million USD
TABLE 49. Europe Cell And Gene Therapy Clinical Trials Market Value, By Phase, 2020-2029, Million USD
TABLE 50. Europe Cell And Gene Therapy Clinical Trials Market Value, By Country, 2020-2029, Million USD
TABLE 51. Germany Cell And Gene Therapy Clinical Trials Market Value, By Application, 2020-2029, Million USD
TABLE 52. Germany Cell And Gene Therapy Clinical Trials Market Value, By Phase, 2020-2029, Million USD
TABLE 53. France Cell And Gene Therapy Clinical Trials Market Value, By Application, 2020-2029, Million USD
TABLE 54. France Cell And Gene Therapy Clinical Trials Market Value, By Phase, 2020-2029, Million USD
TABLE 55. U.K. Cell And Gene Therapy Clinical Trials Market Value, By Application, 2020-2029, Million USD
TABLE 56. U.K. Cell And Gene Therapy Clinical Trials Market Value, By Phase, 2020-2029, Million USD
TABLE 57. Italy Cell And Gene Therapy Clinical Trials Market Value, By Application, 2020-2029, Million USD
TABLE 58. Italy Cell And Gene Therapy Clinical Trials Market Value, By Phase, 2020-2029, Million USD
TABLE 59. Spain Cell And Gene Therapy Clinical Trials Market Value, By Application, 2020-2029, Million USD
TABLE 60. Spain Cell And Gene Therapy Clinical Trials Market Value, By Phase, 2020-2029, Million USD
TABLE 61. Rest of Europe Cell And Gene Therapy Clinical Trials Market Value, By Application, 2020-2029, Million USD
TABLE 62. Rest of Europe Cell And Gene Therapy Clinical Trials Market Value, By Phase, 2020-2029, Million USD
TABLE 63. Asia-Pacific Cell And Gene Therapy Clinical Trials Market Value, By Application, 2020-2029, Million USD
TABLE 64. Asia-Pacific Cell And Gene Therapy Clinical Trials Market Value, By Phase, 2020-2029, Million USD
TABLE 65. Asia-Pacific Cell And Gene Therapy Clinical Trials Market Value, By Country, 2020-2029, Million USD
TABLE 66. China Cell And Gene Therapy Clinical Trials Market Value, By Application, 2020-2029, Million USD
TABLE 67. China Cell And Gene Therapy Clinical Trials Market Value, By Phase, 2020-2029, Million USD
TABLE 68. India Cell And Gene Therapy Clinical Trials Market Value, By Application, 2020-2029, Million USD
TABLE 69. India Cell And Gene Therapy Clinical Trials Market Value, By Phase, 2020-2029, Million USD
TABLE 70. Japan Cell And Gene Therapy Clinical Trials Market Value, By Application, 2020-2029, Million USD
TABLE 71. Japan Cell And Gene Therapy Clinical Trials Market Value, By Phase, 2020-2029, Million USD
TABLE 72. Australia Cell And Gene Therapy Clinical Trials Market Value, By Application, 2020-2029, Million USD
TABLE 73. Australia Cell And Gene Therapy Clinical Trials Market Value, By Phase, 2020-2029, Million USD
TABLE 74. South Korea Cell And Gene Therapy Clinical Trials Market Value, By Application, 2020-2029, Million USD
TABLE 75. South Korea Cell And Gene Therapy Clinical Trials Market Value, By Phase, 2020-2029, Million USD
TABLE 76. Rest of Asia Cell And Gene Therapy Clinical Trials Market Value, By Application, 2020-2029, Million USD
TABLE 77. Rest of Asia Cell And Gene Therapy Clinical Trials Market Value, By Phase, 2020-2029, Million USD
TABLE 78. Rest of World Cell And Gene Therapy Clinical Trials Market Value, By Application, 2020-2029, Million USD
TABLE 79. Rest of World Cell And Gene Therapy Clinical Trials Market Value, By Phase, 2020-2029, Million USD
TABLE 80. Rest of World Cell And Gene Therapy Clinical Trials Market Value, By Country, 2020-2029, Million USD
TABLE 81. Brazil Cell And Gene Therapy Clinical Trials Market Value, By Application, 2020-2029, Million USD
TABLE 82. Brazil Cell And Gene Therapy Clinical Trials Market Value, By Phase, 2020-2029, Million USD
TABLE 83. South Africa Cell And Gene Therapy Clinical Trials Market Value, By Application, 2020-2029, Million USD
TABLE 84. South Africa Cell And Gene Therapy Clinical Trials Market Value, By Phase, 2020-2029, Million USD
TABLE 85. GCC Cell And Gene Therapy Clinical Trials Market Value, By Application, 2020-2029, Million USD
TABLE 86. GCC Cell And Gene Therapy Clinical Trials Market Value, By Phase, 2020-2029, Million USD
TABLE 87. RoW Countries Cell And Gene Therapy Clinical Trials Market Value, By Application, 2020-2029, Million USD
TABLE 88. RoW Countries Cell And Gene Therapy Clinical Trials Market Value, By Phase, 2020-2029, Million USD
RoW Countries Cell And Gene Therapy Clinical Trials Market Value, By Phase, 2020-2029, Million USD

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us